Intraperitoneal chemotherapy in the treatment of advanced ovarian cancer

被引：3
|
作者：
Classe, J. -M. [1 ]
Muller, M. [2 ]
Frenel, J. -S. [3 ]
Rigaud, D. Berton [3 ]
Ferron, G. [4 ]
Jaffre, I. [1 ]
Gladieff, L. [5 ]
机构：
[1] Ctr Rene Gauducheau, Dept Chirurg Oncol, F-44805 St Herblain, France
[2] CHU Nantes, Dept Chirurg Oncol, F-44 Nantes, France
[3] Ctr Rene Gauducheau, Dept Med Oncol, F-44805 St Herblain, France
[4] Inst Claudius Regaud, Dept Chirurg Oncol, Toulouse, France
[5] Inst Claudius Regaud, Dept Med Oncol, Toulouse, France
来源：
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2010年 / 39卷 / 03期
关键词：
Advanced ovarian cancer; Intraperitoneal chemotherapy; Hyperthermic intraperitoneal chemotherapy; HYPERTHERMIC PERITONEAL PERFUSION; HIGH-DOSE CARBOPLATIN; CYTOREDUCTIVE SURGERY; COMPLETE RESECTION; CARCINOMA PATIENTS; PHASE-II; CISPLATIN; RECURRENT; THERAPY; PACLITAXEL;
D O I：
10.1016/j.jgyn.2009.12.007
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
The standard treatment for advanced ovarian cancer consist in complete surgical debulking and intravenous platin and taxane based chemotherapy. Despite research efforts, a lot of patients still die from peritoneal carcinomatosis. The aim of our work was to present the state of art about intraperitoneal chemotherapy. Intraperitoneal chemotherapy (IPC): three multi-institutional randomised trials showed that platin based IPC gave better results in term of overall and disease free survival when compared to standard intravenous treatment. Even so, IPC is not yet becoming a new international standard of treatment because a high rate of morbidity. Hyperthermic Intraperitoneal chemotherapy (HIPEC) represents an innovative alternative to IPC. HIPEC is based on a complete surgical debulking without any visible mass and an intraperitoneal chemotherapy with synergy of hyperthermia. Phase II trails have shown its feasibility. Randomised trials are needed to assess its efficiency in improving survival. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：183 / 190
页数：8
相关论文
共 50 条
  • [21] A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer
    Suidan, Rudy S.
    Clair, Caryn M. St.
    Lee, Stephen J.
    Barlin, Joyce N.
    Roche, Kara C. Long
    Tanner, Edward J.
    Sonoda, Yukio
    Barakat, Richard R.
    Zivanovic, Oliver
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2014, 134 (03) : 468 - 472
  • [22] Comparison of Primary Intraperitoneal Chemotherapy to Consolidation Intraperitoneal Chemotherapy in Optimally Resected Advanced Ovarian Cancer
    Suidan, Rudy S.
    St Clair, Caryn M.
    Lee, Stephen J.
    Barlin, Joyce N.
    Roche, Kara C. Long
    Tanner, Edward J.
    Sonoda, Yukio
    Barakat, Richard R.
    Zivanovic, Oliver
    Chi, Dennis S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (12) : 741 - 742
  • [23] Should we abandon intraperitoneal chemotherapy in the treatment of advanced ovarian cancer? A meta - analysis
    Marti, Maria Teresa Climent
    Ruber, Anna Serra
    Conesa, Teresa Arrufat
    Romera, Maria Llueca
    Abella, Antoni Llueca
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A361 - A362
  • [24] Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer
    Zhang, Ting
    Pan, Qiong
    Xiao, Songshu
    Li, Lijie
    Xue, Min
    ONCOLOGY LETTERS, 2016, 11 (05) : 3287 - 3292
  • [25] Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer: Efficacy, Toxicity, and Future Directions
    Markman, Maurie
    REVIEWS ON RECENT CLINICAL TRIALS, 2007, 2 (03) : 169 - 173
  • [26] Is peritonectomy and hyperthermic intraperitoneal chemotherapy a new standard of treatment for advanced epithelial ovarian cancer?
    Farrell, Rhonda
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2019, 59 (03): : 335 - 340
  • [27] A critical appraisal of hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of advanced and recurrent ovarian cancer
    Chiva, Luis M.
    Gonzalez-Martin, Antonio
    GYNECOLOGIC ONCOLOGY, 2015, 136 (01) : 130 - 135
  • [28] Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer
    Sugarbaker, Paul H.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2009, 21 (01) : 15 - 24
  • [29] Intraoperative Hyperthermic intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer
    Oseledchyk, Anton
    Zivanovic, Oliver
    ONCOLOGY-NEW YORK, 2015, 29 (09): : 695 - +
  • [30] Pharmacokinetics of Taxol Intraperitoneal Chemotherapy for Patients with Advanced Ovarian Cancer
    Wang Yan
    Huang Rongli
    Huang Huifang
    Lang JinghePeking Union Medical Hospital
    现代妇产科进展, 2000, (03) : 238 - 240
12345